Pak Fah Yeow International Limited (SEHK: 239)
Health Care · Pharmaceuticals · HK
HK$2.39
-2.45% today · -2.4% 1Y
Pak Fah Yeow International Limited (SEHK: 239) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $94.91M.
Over the last twelve months the share price has lost 2.4%, trading between 2.24 and 2.73.
Tweenvest scores Pak Fah Yeow International Limited across four factors: quality 76/100, value 62/100, growth 32/100, dividend 50/100. Its strongest factor is quality.
239 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $94.91M
- Revenue (TTM)
- $28.15M
- P/E
- 7.53
- EPS
- 0.32
- Dividend yield
- 8.37%
- Beta (5Y)
- 0.42
- 52-week high
- HK$2.73
- 52-week low
- HK$2.24
- Avg volume (3M)
- —
- Shares outstanding
- 311.64M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Infant Bacterial Therapeutics AB (publ)OM: IBT B | $97.54M | Skr72.40 | +4.17% |
| The Jordanian Pharmaceutical Manufacturing Company - Public Shareholding CompanyASE: JPHM | $97.38M | JD1.52 | -1.30% |
| SAMSUNG PHARM. Co., LTD.KOSE: A001360 | $96.33M | ₩1,376.00 | -3.98% |
| Fusen Pharmaceutical Company LimitedSEHK: 1652 | $95.62M | HK$1.02 | +9.73% |
| Merdury Biopharmaceutical CorporationTPEX: 6932 | $94.16M | NT$7.04 | +15.22% |
| Unité de Fabrication des Médicaments S.ABVMT: UMED | $93.89M | DT8.77 | -0.34% |
| PT Merck TbkIDX: MERK | $93.89M | Rp3,750.00 | -1.06% |
| AlzeCure Pharma AB (publ)OM: ALZCUR | $93.23M | Skr6.76 | -1.46% |
Figures last refreshed Oct 11, 2026.